U.S. General Merchandise and Department Stores Stock News

MeiraGTx Holdings plc recently entered into a private placement agreement to issue 2,376,426 ordinary shares at US$10.52 each for US$25,000,000 in gross proceeds, with closing of the initial sale having occurred in the past on July 17, 2026, and investors retaining the option to purchase up to an additional US$15,000,000 in shares under Regulation D. Alongside a separate agreement for up to US$400,000,000 in funding from Oberland Capital, this mix of non-dilutive royalties and new equity...

Hamilton Insurance Group, Ltd. was recently dropped from the Russell 2000 Dynamic Index but, on July 7, 2026, was added to the Zacks Rank #1 (Strong Buy) List following an 18.5% upward revision in current‑year earnings estimates over the past 60 days. This combination of index exclusion and a Zacks upgrade highlights how differing frameworks can simultaneously reduce passive index exposure while signaling increased analyst confidence in the company’s earnings outlook. Next, we’ll examine how...

On 27 June 2026, Ultragenyx Pharmaceutical Inc. was removed from larger-cap Russell 1000 and Midcap indices and simultaneously added to the Russell 2000, related growth and value benchmarks, and several Russell value indices, reflecting a broad reclassification within the Russell index family. This reshuffling across size and style indices can materially influence trading flows as index-tracking and benchmark-aware investors adjust their portfolios to the new compositions. With Ultragenyx...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

NeuroPace, Inc. ( NASDAQ:NPCE ), is not the largest company out there, but it saw a significant share price rise of 39...

Anyone interested in Sinclair, Inc. ( NASDAQ:SBGI ) should probably be aware that the Independent Director, Daniel...

Royalty Pharma (RPRX) has just been added to both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, a shift that often attracts closer attention from index-tracking and passive funds. See our latest analysis for Royalty Pharma. That index inclusion comes after a period of strong momentum for Royalty Pharma, with a 90-day share price return of 20.67%, a year-to-date share price return of 48.74%, and a 1-year total shareholder return of 66.26%. If you are using this...

The Morning Bull - US Market Morning Update Wednesday, Jul, 8 2026 US stock futures are mixed this morning, with E-mini S&P 500 contracts slightly softer while Dow futures edge higher, as investors weigh fresh signals on inflation and growth. Oil is back above $72 a barrel after tensions in the Strait of Hormuz, which makes fuel more expensive to transport and feeds worries that the cost of living could stay higher for longer. At the same time, the ISM Services PMI at 54.0 shows the largest...

Index removal puts fresh attention on Grocery Outlet Holding Grocery Outlet Holding (GO) was recently removed from both the Russell 2000 Defensive and Russell 2000 Value-Defensive indexes, an index reshuffle that can prompt trading shifts as benchmarked funds rebalance positions. See our latest analysis for Grocery Outlet Holding. For context, Grocery Outlet Holding’s share price has moved to US$10.21, with a 30-day share price return of 19.28% and a 90-day share price return of 43.80%...

SEALSQ guidance and quantum roadmap draw investor focus SEALSQ (LAES) has reaffirmed its 2026 revenue guidance of 50% to 100% growth on audited 2025 revenue of US$18.3 million, while pushing ahead with its post-quantum cryptography product and readiness strategy. See our latest analysis for SEALSQ. Despite SEALSQ’s guidance reaffirmation and progress on its post quantum roadmap, the stock’s recent momentum has cooled, with the share price down 12.5% over 30 days and the year to date share...

MercadoLibre’s share price has delivered a 61.7% gain over the past three years, yet its valuation signals are pulling in different directions, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while market multiples suggest the stock trades at a premium. A 61.7% return over three years suggests MercadoLibre has already rewarded investors who stayed the course. This naturally raises the bar for what counts as good value today. Recent coverage...

With inflation, interest rate debates and energy shocks all pulling markets in different directions, investors are looking for clearer, more focused ideas. The AI Small Caps screener targets smaller companies that are building early-stage tools in areas such as machine learning, automation and data intelligence. These companies are at a stage where growth potential can still be influenced by new products and adoption. This article highlights 3 stocks from that screener, giving you a curated...

Aurinia Pharmaceuticals (AUPH) is drawing fresh attention after announcing PRESERVE, a Phase 4 multicenter study testing its oral lupus nephritis drug LUPKYNIS alongside three established immune therapies. See our latest analysis for Aurinia Pharmaceuticals. The PRESERVE announcement comes after a strong period for Aurinia Pharmaceuticals, with a 1 year total shareholder return of 113.70% and a more moderate 5.67% year to date share price return. This suggests momentum that investors are now...

Global protein markets are being shaken by the Trump administration’s decision to exempt Brazilian beef from proposed 25% tariffs, and that ripple is reaching well beyond ranches. For investors, this kind of trade shock can quickly reshuffle pricing power, costs and demand across traditional meat producers and consumer protein alternatives. This article breaks down three stocks exposed to the news, highlighting one that could see a potential tailwind from shifting consumer preferences and two...

Clean energy and advanced nuclear are back in the spotlight after Google, XTX Markets and others backed a €400mn funding round in fusion start-up Proxima Fusion, valuing it at €2.4bn. For investors, that kind of commitment from major tech and energy companies signals fresh attention on businesses tied to next generation power, data centers and supporting infrastructure. This article breaks down 3 stocks that appear positively exposed to this fusion driven news, helping you think through where...

In the past quarter, Cadre Holdings (NYSE: CDRE) reported a 19.5% year-on-year revenue increase and earnings per share ahead of analyst estimates, with CEO Warren Kanders citing strong momentum extending into 2026. Despite these solid operating results, the reaction suggests investors had set a high bar for performance and outlook, highlighting how expectations can shape the interpretation of even upbeat earnings. Next, we’ll examine how Cadre’s earnings beat and CEO’s comments on momentum...

On 27 June 2026, TIC Solutions, Inc. (NYSE:TIC) was removed from multiple Russell indexes, including the Russell 2000 Defensive, 2500 Growth, 3000E Growth, and several growth-defensive and value-defensive benchmarks. This broad index exclusion reduces automatic index-linked ownership of TIC shares and may change how both passive and active investors view the company’s profile. We’ll now examine how TIC Solutions’ removal from several key Russell benchmarks shapes the company’s existing...

In June 2026, AnaptysBio, Inc. was removed from several Russell indices, including the Russell Microcap, Russell 3000E, and related growth benchmark indices, triggering index rebalancing by passive funds. This broad removal from key Russell benchmarks may influence how investors perceive AnaptysBio’s visibility, liquidity, and role within the small-cap biotech universe. We’ll now examine how AnaptysBio’s exit from multiple Russell indices shapes its investment narrative, especially around...

Tariff headlines are back at the center of the market conversation, with President Trump pushing for broad new charges on imports from the EU and dozens of other countries, while legal challenges and rising costs for businesses add to the uncertainty. For investors, that kind of policy volatility tends to reward close attention to companies most exposed to shifting trade rules and imported inputs. This article breaks down three stocks from the Tariff Exposure Plays Amid Volatile US Trade...

In late June 2026, Flywire Corporation (NasdaqGS: FLYW) was added to the Russell 2000 Defensive, Growth-Defensive, and Value-Defensive indexes. This inclusion places Flywire on the radar of index-tracking funds and asset managers that follow Russell’s defensive and style-focused small-cap benchmarks. Next, we’ll explore how Flywire’s addition to multiple Russell 2000 defensive-style indexes may influence its broader investment narrative. Rare earth metals are the new gold rush. Find out...

Fresh coverage on Bentley Systems (BSY) is drawing attention after BNP Paribas and Bank of America highlighted the company as a potential defensive AI play, citing structural advantages in its core infrastructure software markets. See our latest analysis for Bentley Systems. Despite fresh coverage, Bentley Systems’ recent share price performance has been mixed, with the stock down about 7% over the past 90 days and the 1 year total shareholder return declining around 42%. This underlines why...

Recently, TransDigm Group reported quarterly earnings of US$9.85 per share, surpassing consensus forecasts, while analysts highlighted its strong record of outperforming expectations and its high-margin, recurring aftermarket aerospace revenue base. An interesting angle is that analysts are increasingly focusing on TransDigm’s proprietary components and recurring aftermarket cash flows as key supports for its earnings resilience. We’ll now examine how this increasingly bullish earnings...

Index removal puts Innoviva in focus Innoviva (INVA) has just been dropped from several Russell growth and small cap benchmarks. This type of change can prompt index-tracking funds to rebalance and may lead to increased short term trading activity in the stock. See our latest analysis for Innoviva. At a share price of US$22.25, Innoviva has seen mixed momentum, with the share price return up 11.98% year to date but down over the past quarter. Longer term total shareholder returns of 16.74%...

The Greenbrier Companies, Inc. recently reported third-quarter 2026 results showing revenue of US$576.5 million and net income of US$18.9 million, both lower than the same period a year earlier, alongside weaker earnings per share from continuing operations. Despite softer earnings and the completion of a long-running buyback program, management affirmed a quarterly dividend of US$0.34 per share, signaling confidence while balancing shareholder returns with current operating conditions. With...